Hypothyroidism

Lancet

Volumn 349, Issue 9049, 1997, Pages 413-417

  Lindsay, Robert S ^a   Toft, Anthony D ^a  

^a NHS LOTHIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; THYROID HORMONE; THYROTROPIN; THYROXINE;

ARTICLE; BONE METABOLISM; CHOLESTEROL BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; PATIENT MONITORING; PRIORITY JOURNAL; SYMPTOM; THYROID FUNCTION TEST; THYROID HORMONE RELEASE; THYROTROPIN BLOOD LEVEL; UNITED KINGDOM;

EID: 0031040398     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)80050-5     Document Type: Review

References (30)

1. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
2. Fisher DA. Clinical review 19: management of congenital hypothyroidism. J Clin Endcrinol Metab 1991; 72: 523-29.
3. Fung HYM, Kologlu M, Collison K, et al. Postpartum thyroid dysfunction in Mid Glamorgan. BMJ 1988; 296: 241-44.
4. Sawers JSA, Toft AD, Irvine WJ, Brown NS, Seth J. Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis. J Clin Endocrinol Metab 1980; 50: 226-29.
5. Toft AD, Irvine WJ, Sinclair I, McIntosh D, Seth J, Cameron EHD. Thyroid function after surgical treatment of thyrotoxicosis: a report of 100 cases treated with propranolol before operation. N Engl J Med 1978; 298: 643-47.
6. Spencer C, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalised patients. Clin Chem 1987; 33: 1391-96.
7. Topliss DJ, White EL, Stockigt JR. Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab 1980; 50: 52-56.
8. Faglia G, Bitensky L, Pinchera A, Ferrari C, Parrachi A, Beck-Peccoz P. Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab 1979; 48: 989-98.
9. Nicoloff JT, LoPresti JS. Myxoedema coma: a form of decompensated hypothyroidism. Endocrinol Metab Clin North Am 1993; 22: 279-90.
10. Oppenheimer JH, Braverman LE, Toft A, Jackson IM, Ladenson PW. A therapeutic controversy: thyroid hormone treatment: when and what? J Clin Endocrinol Metab 1995; 80: 2873-83.
11. Toft AD. Thyroxine therapy. N Engl J Med 1994; 331: 174-80.
12. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83.
13. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years: a study in an urban US community. Arch Intern Med 1990; 150: 785-87.
14. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145: 1386-88.
15. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgeway ED. L-thyroxine therapy in subclinical hypothyroidism: a double blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18-24.
16. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double blind cross over 12 month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) 1988; 29: 63-75.
17. Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid function in the elderly. Microsomal antibodies as a discriminant for therapy. JAMA 1987; 258: 209-13.
18. Davies PH, Franklyn JA, Daykin J, Sheppard MC. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine. J Clin Endocrinol Metab 1992; 74: 1189-94.
19. Roti E, Braverman LE. Thyroid hormone therapy: when to use it, when to avoid it. Drug Therapy 1994; 24: 28-30; 32-34; 54-55.
20. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hyperthyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992; 92: 631-42.
21. Bogner U, Arntz HR, Peters H, Schleusener J. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol 1993; 128: 202-06.
22. Franklyn JA, Daykin J, Betteridge J, et al. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf) 1993; 38: 453-59.
23. Parle JV, Franklyn JA, Sheppard MC. Thyroxine replacement therapy. Lancet 1991; 337: 171.
24. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol (Oxf) 1992; 37: 500-03.
25. Leslie PJ, Toft AD. The replacement therapy problem in hypothyroidism. Baillieres Clin Endocrinol Metab 1988; 2: 653-59.
26. Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1993; 77: 334-38.
27. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-52.
28. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur Endocrinol 1994; 130: 350-56.
29. Solomon BL, Wartofsky L, Burman KD. Prevalence of fractures in post-menopausal women with thyroid disease. Thyroid 1993; 3: 17-23.
30. Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf) 1988; 28: 325-33.